EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

03.06.08

USPTO As Broken as Always, Proof Herein

Posted in Free/Libre Software, Hardware, Patents at 2:03 am by Dr. Roy Schestowitz

Repeating the same mistakes of the drug industry

Whenever you find comfort in the belief that you have seen enough, here comes another disturbance. This one is from RIM.

What do you get if you mesh a dual-orientation handset together with a slide-out keyboard and a tracker ball? Potentially, the next BlackBerry from Research in Motion (RIM), if its latest patent application is anything to go by.

USPTOWhat RIM patents here has plenty of prior art and we recently saw an incident where RIM actually sued unnecessarily, attacking a weaker company like Motorola using weak patents applicable to wireless communication standards. The Nokia N810 and the Mylo from Sony seem rather similar to the design in this patent application, but this does not seem to bother or deter RIM. Remember what these people think: More Patents = More Innovation. But not so fast!

It seems like a patents blog has just shown up (or been born) in C|Net and it now speaks about the “first-to-file” rule, which renders the whole system utterly pointless and prone to error.

Generally, the first person to file the lawsuit gets to choose where the suit is brought. This is called the “first-to-file” rule. It works much like the lines you stand in at the grocery store, airport security, or countless other places; it’s simply first come, first served.

However, in the context of patent litigation, being first in line is a big deal. Different courts have different procedural rules that can affect the way a case is litigated and the speed at which the case goes to trial. Moreover, there is a perception that courts in certain areas are more plaintiff-friendly than others.

The term “first-to-file” is used in numerous other circumstances which equally well demonstrate the weakness of the whole approach. The pharmaceutical industry is already learning its lessons, so why can’t others?

Below we’re appending some relevant and recent stories about conclusions arrived by drug companies and biologists. They are sorted reverse-chronologically (roughly).


1. Open Lab

The open source wave could soon power drug discovery initiatives in the country. A decentralised, web-based initiative is emerging that would enable scientists from laboratories, universities, institutes, and drug Companies to work together in discovering new drugs for diseases like tuberculosis (TB), malaria, various types of cancer, AIDS, Chikungunya, Kala-azar, dengue fever, etc.

2. Open-source model for drug discovery?

Significant public funding along with the ability for private enterprise to benefit from the open source approach will result in a strong public-private partnership and ensure success of the open source approach.

3. Open source drug discovery

The idea, taking off from successful open source models such as the human genome sequencing initiative, is very simple. All the relevant data and accumulated intelligence on a particular disease, tuberculosis to begin with, would be hosted online.

4. ‘Open source’ urged for TB drug design effort

One of India’s top genetics researchers has called for a global, collaborative effort to design a new tuberculosis (TB) drug using an ‘open source’ approach.

5. Open Source Pharmaceuticals – New Business Model

Software is not the only field affected by open source; many fields of study and social and political views have been affected by the growth of the concept of open source. Advocates in one field will often support the expansion of open source in other fields, including Linus Torvalds who is quoted as saying, “the future is open source everything.”

6. Open source synthetic biology

Not everyone within synthetic biology takes the open-source approach, Andrew Hessel, an iGEM consultant who recruits teams from Canadian universities, told me, but the driving force behind it is iGEM and MIT (Rettberg works with renowned hacker-turned-synthetic biologist Tom Knight). Hessel likened the atmosphere to the time when computers were first becoming cheap enough to be affordable by anyone who wanted one, and young, bright kids began to play around with code.

7. Biology Goes Open Source

Some of the world’s biggest drug companies are finding that their genetic research is worth more to them if they give it away.

8. Pharmac publishes directly with open source

The team used Python, libxml/libxslt and TeX, running on Debian GNU/Linux, and the open document standards TeX, XML, MathML, XHTML, and Xlink, says Geering.

9. Open Source Research — the Power of Us

Open source methods have delivered tangible benefits in the computer science community. We describe here efforts to extend these principles to science generally, and in particular biomedical research. Open source research holds great promise for solving complex problems in areas where profit-driven research is seen to have failed. We illustrate this with a specific problem in organic chemistry that we think will be solved substantially faster with an open source approach.

10. Our Biotech Future [is Open Source]

Open Source biology could be a powerful tool, giving us access to cheap and abundant solar energy.

11. Open-Source Drug Safety?

More than a million Americans take Avandia every year; the risk Glaxo had found would mean thousands of extra heart attacks. But the company argued that the risk only occurred in patients who already had serious heart problems, and that it didn’t show up in long-term clinical trials. The FDA made no decision, and no public statement.

[...]

It’s an open source approach to drug safety.

12. Open Source Pharmaceuticals – New Business Model

“Open source” as applied to culture defines a culture in which intellectual property is made generally available. Participants in such a culture are able to improve and modify those products and redistribute them back into the community.

13. Thailand fed up with high drug prices – minister

“We have thought about this for more than five years. It’s long enough,” said Mongkol na Songkhla, who is leading one of the biggest challenges to Big Pharma’s patent rights in years.

In relation to this:

“Collaboration reduces development costs and subsequent high prices, and therefore precludes the need for patents. Took them long enough to figure that out, didn’t it?”

Slated, March 4th 2008

Time for change. Software patents do more harm than good.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

A Single Comment

  1. mcintosh said,

    March 6, 2008 at 7:58 am

    Gravatar

    You want proof that our patent system is broken? Look up US patent number 6,960,975. Not only is there a metric (donkey)load of prior conceptual art in at least a half century’s science fiction, but reduction to practice is not presently possible.

What Else is New


  1. Links 22/10/2019: MX-19, Tails 4, Mesa 19.1.8 Released

    Links for the day



  2. “Stallman Was Right” is Not Just a Meme as It's Usually True

    The track record of Stallman isn't immaculate, but it's exceptionally good if not impressive



  3. EPO Diplomatic Immunity

    What people can get away with at the European Patent Office (EPO) if their name is Battistelli or António Campinos



  4. Dr. Ingve Björn Stjerna Reveals How the German Government Actively Ignored SMEs to Push the Notorious 'Unitary Patent' Sham

    Turning European Patents (which are no longer good patents but expensive or overpriced patent monopolies — patents which European courts will likely reject) into “unitary” ones (i.e. enforceable EU-wide with one legal action) would harm wrongly-accused parties that mostly or only operate in one single country, overriding the authority of those parties’ national laws and courts



  5. Links 22/10/2019: Pacman 5.2, Shame of Disney+ DRM, Microsoft's DRM Scheme, Microsoft Reprimanded for Privacy Abuses

    Links for the day



  6. Patents Need to Exist Only to Pass Information Around and Keep Good Ideas Alive, Not to Feed Litigation Firms and Litigation 'Enthusiasts'

    The current situation or the status quo where legal professionals are advised not to even look at patents means that patents aren’t for “information” and “innovation” anymore; moreover, calling them “intellectual property rights” (or IPRs) is spreading a malicious lie



  7. IRC Proceedings: Monday, October 21, 2019

    IRC logs for Monday, October 21, 2019



  8. SUEPO Protest Tomorrow. All EPO Staff in Munich Ought to Attend and Prepare to Strike Too.

    Tomorrow’s planned protest should be a bridge towards a full strike, which takes more time to plan for and get authorisation for (because of increasingly strict restrictions)



  9. Looking for Explanations About Samsung's DeX and Other FOSS Initiatives Being Canned

    DeX was primarily a threat to the desktop/laptop monopoly of Microsoft, so its sudden abandonment — without even an explanation — continues to attract speculations



  10. EPO Will Need a Lot More Than Photo Ops and Hoax 'Studies' to Restore the Perception of Lawfulness

    Battistelli‘s illegal attacks on European Patent Office (EPO) judges have tarnished any impression that the EPO serves justice and the current regime torpedoes an assessment of these attacks; EPO workers understand that to follow guidelines from the management may be a breach of the EPC



  11. Links 21/10/2019: More on DeX, Disney DRM and Linux 5.4 RC4

    Links for the day



  12. GNU/Linux is Bigger Than Ever (Used More Than Ever Before), But Communication Means and Brands Have Changed

    The GNU/Linux market is alive and healthy; it's how we measure its health that ought to adapt because things are constantly changing, more rapidly in the realm of technology than anywhere else



  13. IRC Proceedings: Sunday, October 20, 2019

    IRC logs for Sunday, October 20, 2019



  14. Samsung Does Not Say Why It's Dropping DeX, But the ASUS EEE Story Might Offer Clues

    It's not at all outlandish or unreasonable to suggest that Microsoft used patents or bribes or kickbacks as incentives for Samsung to abandon GNU/Linux as a desktop platform



  15. EPO: It's Only Getting Worse

    Inhaling Seagull meme for EPO presidents



  16. It Has Begun: EPO Staff Protests Against António Campinos (Starting Wednesday)

    Wednesday marks the resumption of EPO protests; it’s happening for the first time under Campinos and only a year after he took Office. Even Battistelli, the notorious thug, lasted longer before such escalations/actions or — put another way — he did better than that (if one checks the timeline of his presidency)



  17. Links 20/10/2019: GNU/Linux at Penn Manor School District, Wine-Staging 4.18, Xfce 4.16 Development, FreeBSD 12.1 RC2

    Links for the day



  18. Guest Post: Understanding Autism for More Complete Inclusion

    "...assuming that autistic people are all the same isn't only technically wrong, it is misleading and leads to harmful and needless misunderstandings."



  19. Guest Post: Free Software Freedom is Not a Freedom of Choice

    The concept of "Freedom of Choice" and how the ruling class uses it to give a false impression of "Freedom"



  20. Guest Post: Free Software Developers and Pursuing 'Market Share'

    "The only people interested in software freedom are (almost always) free software developers. And users are interested in freedom to a very limited extent: the "free beer" side. Even many free software developers are only interested in the "free beer" part of free software."



  21. The Assertion That Microsoft Uses Communist Tactics Against GNU/Linux and Free/Libre Software

    A study of Taistoism might help understand how Free/libre software is being undermined



  22. European Patent Office and US Patent and Trademark Office Cranks Discovered Buzzwords, Stopped Worrying, Started Granting Patents They Know to be Fake

    The world's patent repositories are being saturated with loads of junk patents or patents that have no legal bearing but can still be leveraged for extortion purposes; the EPO is resorting to lies and artificially-elevated buzzwords to justify granting such fake (yet ruinous) patents



  23. IRC Proceedings: Saturday, October 19, 2019

    IRC logs for Saturday, October 19, 2019



  24. “The True Hypocrite is the One Who Ceases to Perceive His Deception, the One Who Lies With Sincerity,” Said André Paul Guillaume Gide (Nobel Prize in Literature)

    Lies flow like water in the realm of EPO and its publishers, whose sole role is dissemination of deliberate falsehoods, misnomers and misinformation



  25. The EPO Cannot Guard Fake European Patents From Scrutiny (in the Long Run)

    Legal certainty associated with newly-granted European Patents is already pretty low and as long as the EPO refuses to acknowledge that its courts (or boards) lack autonomy the EPO merely brushes a growing problem under the rug



  26. Links 19/10/2019: DeX Discontinued, DXVK 1.4.3 and Wine 4.18 Released

    Links for the day



  27. 'Corporate Linux' Will Not Protect Software Freedom

    The corporate model is inherently not compatible with software that users themselves fully control (or Software Freedom in general), so we must rely on another model of sovereignty over code and compiled code (binaries)



  28. IRC Proceedings: Friday, October 18, 2019

    IRC logs for Friday, October 18, 2019



  29. 26,000 Posts

    We want to thank those who help spread the word; it gives us moral support and morale.



  30. The Myth of 'Analysts'

    People with exaggerated roles (exaggerated by corporate media and corporations that control them) distort public perceptions about their clients; they're in effect just elevated marketing or Public Relations (PR) operatives


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts